| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 571 |
| 1 | METHOTREXATE SODIUM | 555 |
| 2 | METHOTREXATE | 501 |
| 3 | NIVOLUMAB | 395 |
| 4 | TACROLIMUS | 387 |
| 5 | CYCLOPHOSPHAMIDE | 361 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 361 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 361 |
| 8 | PREDNISOLONE | 357 |
| 9 | PREDNISOLONE ORAL | 357 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEVACIZUMAB-MALY | 7 | 0.0348 |
| 1 | BETAXOLOL HYDROCHLORIDE | 16 | 0.0307 |
| 2 | EPINEPHRINE HYDROCHLORIDE | 12 | 0.0253 |
| 3 | FLUCYTOSINE | 30 | 0.0212 |
| 4 | DAUNORUBICIN HYDROCHLORIDE | 22 | 0.0133 |
| 5 | ALBENDAZOLE | 23 | 0.0121 |
| 6 | FOSCARNET SODIUM | 46 | 0.0114 |
| 7 | ISOFLURANE | 21 | 0.0107 |
| 8 | CIDOFOVIR ANHYDROUS | 14 | 0.0097 |
| 9 | CEFIDEROCOL SULFATE TOSYLATE | 3 | 0.0095 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1382 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1008 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 580 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 540 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 487 |
| 5 | Alkylating Drug [EPC] | 459 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 426 |
| 7 | Platinum-based Drug [EPC] | 324 |
| 8 | Kinase Inhibitor [EPC] | 317 |
| 9 | Benzodiazepine [EPC] | 314 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 30 | 0.0212 |
| 1 | Interleukin-5 Antagonist [EPC] | 11 | 0.0160 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1008 | 0.0102 |
| 3 | Anthelmintic [EPC] | 27 | 0.0093 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 45 | 0.0077 |
| 5 | Tubulin Inhibiting Agent [EPC] | 2 | 0.0069 |
| 6 | Human Immunoglobulin G [EPC] | 111 | 0.0053 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 58 | 0.0045 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 212 | 0.0044 |
| 9 | Programmed Death Ligand-1 Blocker [EPC] | 88 | 0.0041 |